Level 41Australia Square
264 George Street
Sydney NSW 2000
+61 (0)2 8088 4760
1 week ago
THC Global Group Ltd ASX Announcement:
Successful completion of $6.6 million Institutional Placement.
thc.global/wp-content/uploads/2020/06/THC-Global-Completes-6.6-million-Institutional-Placement.pdf ... See MoreSee Less
2 weeks ago
THC Global Commences Production Deal with CANNATREK.
- THC Global and Cannatrek have signed a 12 month production deal, utilising Cannatrek’s expert cultivation and THC Global’s world-class pharmaceutical production at the Southport Facility
- THC Global to develop and manufacture Cannatrek branded medicines on contract
- Cannatrek provide cannabis biomass to THC Global for production of both Cannatrek medicines and
an additional quantity for THC Global’s own production of Canndeo branded medicines
THC Global Group CEO Ken Charteris "This is a significant milestone for THC Global and Cannatrek, but also for the Australian medicinal cannabis industry. By utilising our Southport Facility to produce high quality medicinal cannabis medicines for Cannatrek’s brand as well as our Canndeo brand, we’re increasing the number of Australian produced medicines available to patients, and supporting the development of the industry as a whole."
bit.ly/2ULq4Cb ... See MoreSee Less